Markham, Canada
Exact Imaging, founded in 2003, is a pioneering company in the field of Biotechnology and Medical Devices, based in Canada. With a focus on enhancing prostate cancer diagnostics, the company uses its proprietary technology to offer high-resolution micro-ultrasound systems that assist urologists in conducting targeted prostate cancer biopsies efficiently.
The company's flagship product, the ExactVu™ micro-ultrasound platform, boasts a resolution of 29 MHz and integrates seamlessly into existing urological workflows. This system, alongside the FusionVu™ micro-US/MRI fusion application, provides significant benefits in terms of affordability and operational efficiency. This sophisticated approach has earned regulatory approvals across major markets, including the EU (CE Mark), the US (FDA 510(k)), and Canada (Health Canada license).
Recently, Exact Imaging received a $5.10M Convertible Note investment in March 2021 from prominent investors, including Export Development Canada and the Business Development Bank of Canada, further substantiating its market potential and growth trajectory.
